Hypoglycemia Caused by the Concurrent Administration of Oral Antidiabetic Agents for Type 2 Diabetes and Vonoprazan for Helicobacter Pylori Eradication: A Case Report

DOI

Bibliographic Information

Other Title
  • ボノプラザン使用ピロリ菌除菌により低血糖を呈した経口血糖降下薬使用中2型糖尿病患者の1例

Search this article

Abstract

<p>Although there have been some reports of hypoglycemia due to the combined use of sulfonylureas (SU), such as glibenclamide, glyburide, and glipizide, and Helicobacter pylori-eradicating agents, no cases of hypoglycemia due to the combined use of glimepiride, which is frequently used in Japan, and H. pylori-eradicating agents have been reported. Furthermore, no cases of hypoglycemia due to H. pylori eradication using vonoprazan, a novel antacid, have been reported. We herein describe the case of a patient with type 2 diabetes who was treated with glimepiride, who developed hypoglycemia following the administration of vonoprazan, and who recovered from hypoglycemia upon the completion of H. pylori eradication treatment.</p>

Journal

Keywords

Details 詳細情報について

Report a problem

Back to top